Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Dec 18, 2022 9:42am
323 Views
Post# 35178303

RE:RE:RE:RE:RE:NSCLC and GBM indications

RE:RE:RE:RE:RE:NSCLC and GBM indications We do not know why any particular advisors or employees are no longer associated with Theralase. Maybe they were asked to leave or maybe they chose to leave for reasons of their own. One thing we know for sure - the number of people Theralase has to pay salaries or stipends to has been drastically reduced in the last 2 years and this can be verified by looking at the "Our Team" from 2 years ago and comparing it with today's. The Company has told us on several occasions that there was a hiring freeze in place and that many employees had been let go as an economy measure. Theralase has to stretch it's limited funds while minimizing dilution until it reaches the promised land of the  commercialization of TLD1433 pdt.



Infinity wrote: Hey Science first, I will grant you, you are a good spin Doctor.  There was no reason given by the management for Dr. Micheal Jewett leaving the MSAB.  Dr. Kulkarni was not on the MSAB as far as I Know. This management has been far from transparent on many issues.  We do not know why Shawn Shirazi was asked to leave.  We do not know the real reason for why Dr. Vera Madzervic was asked to leave the company,  All the more reason from the share holders perspective to have transparent communication.  We may have the best technology in terms of  treatment of Bladder cancer, cure for Brain cancer, cure for lung cancer, even a treatment for corona virus and similar virus,  this company remains opaque in terms of communication and the founder of this company is restricted from holding any management position.  This speaks for everything inspite of your SPIN DOCTORING.


<< Previous
Bullboard Posts
Next >>